![]() |
|
|
3 Department of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802; 4 National Institute for Nutrition and Food Safety, Chinese Centre for Disease Control and Prevention, Beijing, China 100050; 5 Institute of Medical Nutrition, Qingdao, China 266021; and 6 USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111
* To whom correspondence should be addressed. E-mail: mhg{at}psu.edu.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Because one of the determinants of the dietary requirements for VA is VA utilization, it is important to determine the factors that influence VA turnover and disposal. Previous work in humans and rats has demonstrated that different nutritional (5,6), environmental (7,8), and disease conditions (9–12) alter VA homeostasis. Studies in rats have established that, as VA intake and stores increased, there was a parallel increase in VA utilization (13). Similarly, Hicks et al. (14) reported that biliary VA disposal was higher in rats with high hepatic stores of the vitamin. When VA turnover was quantified in rats with low, marginal, and high liver VA stores by Green et al. (15), the results showed that VA disposal and turnover were different among the groups, suggesting that VA kinetics responds to changes in dietary VA intake. Finally, Kelley and Green (16) investigated the factors that influence VA disposal in VA-adequate rats under conditions of low VA intake. The authors showed that, if liver stores were adequate, VA disposal was not decreased to compensate for low VA intake as long as plasma retinol concentration was normal, suggesting that VA disposal is also influenced by plasma retinol concentrations.
Although these studies have delineated some of the underlying mechanisms governing VA turnover in rats, only a few studies (17–19) have examined VA kinetics in humans. For instance, Sauberlich et al. (17) showed that VA disposal is related to total body stores, noting that both plasma VA concentration and utilization rate decreased during depletion to conserve VA when intake was low. More recently, von Reinersdorff et al. (18,19) utilized a stable isotope method to describe and quantify the absorption and metabolism of retinyl palmitate in men. A compartmental model developed to fit data for 1 of the subjects predicted that retinol recycling through plasma was substantially higher than the VA disposal rate (19), as has also been shown in rats (20).
In view of the limited data on VA turnover and disposal in humans, we developed a compartmental model that describes and quantifies the kinetics of VA absorption and metabolism following the oral administration of a stable isotope of VA to well-nourished Chinese (21) and American adults (22). In addition to the quantitative and descriptive information obtained from the models, our results confirm the hypothesis that, in individuals with normal VA status, VA disposal rate is influenced more by VA stores than by serum retinol levels.
| Subjects and Methods |
|---|
|
|
|---|
Subjects.
As part of 2 larger studies that examined the conversion of β-carotene to retinol in Chinese (21) and U.S. adults (22), data from a subset of participants (n = 14 Chinese, 12 US) were analyzed using model-based compartmental analysis (see below). All volunteers had the following characteristics: 40–71 y old; nonsmokers; had not taken a VA or β-carotene supplement within the past month; had body weights within 20% of the standard for their height and a BMI
30 kg/m2; and had no acute or chronic disease signs or symptoms (21,22). Informed written consent was obtained from all volunteers under the guidelines established by both the Ethical Review Committee of the Institute of Nutrition and Food Hygiene, Chinese Academy of Preventive Medicine and the Human Investigation Review Committee of Tufts University, Tufts-New England Medical Center for the Chinese participants and from the Tufts Review Committee for the American subjects.
Study design and kinetic studies. The studies were conducted as described previously (21,22). Briefly, during the 2 wk prior to entering the experiment, participants were instructed by a dietitian to avoid vitamin supplements or foods containing large amounts of VA or β-carotene. Following the 2-wk introductory period, participants were housed in a metabolic research unit for a 10-d resident stay. After this, each participant was free-living from d 11 to 56; subjects were instructed not to consume vitamin supplements or foods containing large amounts of VA or β-carotene and dietitians followed up with each participant to ensure compliance.
On d 4 of the resident stay, participants swallowed a capsule containing 3 mg [2H8]RAc (8.9 µmol) in 170 mg corn oil and consumed a formulated liquid breakfast containing 25% energy from fat (21,22). Serum samples were collected by venipuncture at baseline and 3, 5, 7, 9, 11, and 13 h following administration of [2H8]RAc. In addition, fasting serum samples were collected daily for the following 6 d and then weekly for 7 wk. Aliquots of serum were stored at –70°C for subsequent analysis.
Analytical procedures. Aliquots of serum (100 µL) were extracted in 3 mL of chloroform:methanol (2:1, v:v) as described earlier (22). Samples were mixed by vortexing, centrifuged at 800 x g for 10 min at 4°C and the chloroform layer was collected. The remaining aqueous phase was reextracted with 2 mL of hexane, which was combined with the chloroform layer. The organic phase was dried to completeness under nitrogen gas using an N-EVAP (Organomation Associates). The residue was dissolved in 100 µL of ethanol and retinoid masses were quantified by reverse-phase HPLC (22). The percent enrichment of labeled retinol derived from RAc was determined using GC-electron capture negative chemical ionization MS as previously described (22).
Kinetic analysis and parameters. Data on fraction of the administered dose remaining in serum at each time were calculated as serum tracer concentration divided by the dose divided by the estimated serum volume. Serum volume was calculated as body weight (g) x 0.038 mL serum/g body weight (23). Then, using the Windows version of the Simulation, Analysis and Modeling computer program (WinSAAM) (24), we employed model-based compartmental analysis (25) to characterize whole-body VA kinetics for each individual as viewed from the plasma space. In this form of compartmental analysis, processes with similar kinetics are lumped in the same compartment. To determine the simplest model that would adequately fit the data for serum, model complexity was increased only when it resulted in a significant improvement in the weighted sums of squares as determined by an F-statistic (26). Once a satisfactory fit for each individual was obtained, weighted nonlinear regression analysis (fractional SD = 0.05) using WinSAAM was applied to obtain the final estimates of the fractional transfer coefficients [L(I,J); see below].
The following kinetic parameters were determined for each individual; see Green and Green (25) for more details. The L(I,J) (d–1) are defined as the portion of VA in compartment J that is transferred to compartment I each day. Mean transit time [t(I); d] is defined as the average length of time that a molecule of VA that reaches compartment I remains in compartment I before it leaves that compartment reversibly or irreversibly. The average time for a molecule of VA to appear in the blood after ingestion of the oral dose was calculated by summing the transit times in each compartment that preceded the appearance of labeled retinol in serum. Serum VA pool sizes (µmol) were estimated from each individual's average serum VA concentration during the study and their estimated serum volume. Then, serum VA pool sizes were used in a steady-state solution in WinSAAM to estimate VA pool sizes or traced mass [M(I); µmol] and residence times [T(I,J); d; the average of the distribution of times that a molecule of retinol spends in compartment I before leaving that compartment irreversibly after entering the system via compartment J]. Because kinetic parameters were calculated assuming a steady state and given the relatively short duration of the study, VA input rate was set equal to the disposal rate.
Determination of total-body VA using isotope dilution.
Serum tracer ([2H8]retinol) and tracee (retinol) were used to estimate total-body VA using the deuterated retinol dilution (DRD) technique (27). Briefly, total-body VA was calculated at 24 d after tracer administration using the equation:
![]() |
where F is the fraction of dose absorbed and retained (estimated to be 0.5), S is the ratio of the specific activity of retinol in serum to that in liver (estimated to be 0.65), a is the correction for loss of tracer via catabolism (a = e–kt, where k = 140 d), and H:D-1 is the measured tracee:tracer ratio corrected for the contribution of the mass of tracer retinol to total-body VA (27,28). We applied the DRD equation using data from d 24, because it has been estimated that it takes
20 d for orally administered labeled VA to mix with endogenous body pools (17,29,30). In addition, to determine whether total-body VA stores could be estimated at an earlier time, we modified the DRD equation by using d 3 tracee and tracer data to calculate both a ratio of specific activity of retinol in serum to that in liver (a) and a H:D ratio. We also estimated the fraction of dose absorbed and retained (F) to be 0.75 as opposed to 0.5 (31). Using these values in the above equation, total-body VA was calculated at 3 d after tracer administration.
Statistics. All results are expressed as means ± SD. When appropriate, data were log-transformed to meet normality assumptions prior to statistical analysis. Kinetic data were compared statistically using a Student's unpaired t test in Microsoft Excel (2001 version); P < 0.05 was considered significant. Simple regression was performed using SuperANOVA (Abacus Concepts) on individual data, with P < 0.05 considered significant.
| Results |
|---|
|
|
|---|
|
12 h after dose administration. Subsequently, there was a rapid disappearance of tracer from serum in both groups that persisted until
5 d after dose administration. Then, the serum tracer response curves began to flatten as each curve entered a shallow terminal slope. The decrease in slope of the curves indicates extensive recycling of retinol to serum prior to
8 d after tracer administration. The sharpness of the bend in the curves indicates adequate stores of VA in both groups (i.e. tracer specific activity was diluted by mixing with slow turning-over pools of VA). In addition, as reflected in terminal slopes of the representative curves shown here, the serum tracer response profiles indicated that the total traced mass was larger in the U.S. participants and that the system fractional catabolic rate was higher in the Chinese participants. Both of these qualitative observations were confirmed and quantified by subsequent compartmental modeling.
|
|
|
|
42% larger in the U.S. group than in the Chinese group, whereas the serum VA T(I,J) was
63% larger in the Chinese group. In addition, the model-predicted VA mass and T(I,J) in compartment 6 (the slowly turning-over extravascular pool) were
283% and 37% larger, respectively, in the U.S. participants.
Compartmental modeling also predicted differences between groups in the VA disposal rate and the days of VA stores. The estimated average VA disposal rate (Table 3) for the U.S. group was
163% greater than that for the Chinese group. Based on differences in the model-predicted L(I,J) (Table 2), compartment masses (Table 3), and disposal rates (Table 3), we estimate that the U.S. adults had 37% more days of VA stores than the Chinese adults (Table 3).
To determine whether serum retinol pool size [M(5)], serum retinol concentration, and/or the model-predicted traced mass in the slow turning-over compartment [M(6)] affect VA utilization, the model-predicted VA disposal rates were compared with these variables using linear regression analysis. In both the Chinese and U.S. participants, VA disposal rate was significantly correlated with the traced mass in compartment 6 (the extravascular compartment), with the disposal rate increasing linearly with increasing VA stores (Fig. 3A,B). In addition, VA disposal rate was correlated with serum retinol concentration in the Chinese participants (R2 = 0.336; P < 0.05; data not shown) but not with serum retinol pool size; VA disposal rate was not correlated with either serum retinol concentration or serum retinol pool in the U.S. group (data not shown). The strongest correlations were observed when individuals in both groups were combined (Chinese and US, n = 26). In all individuals, VA disposal rate was directly correlated with VA mass in the extravascular compartment (Fig. 4A), with serum retinol concentration (Fig. 4B), and with the serum retinol pool size (Fig. 4C). Additionally, serum retinol concentration was correlated with VA mass in the extravascular compartment (R2 = 0.231; P < 0.05; data not shown).
|
|
4.7 times larger in the U.S. group than in the Chinese group (Fig. 5). Total-body VA pool size did not differ between data from 3 vs. 24 d after dose administration. Furthermore, the model-predicted VA mass in compartment 6 and the calculated total-body VA pool size at 3 or 24 d in the Chinese or U.S. participants did not differ.
|
| Discussion |
|---|
|
|
|---|
Using WinSAAM, we developed a 6-compartment model (Fig. 2) that describes the digestion, absorption, hepatic processing, and turnover of VA in Chinese and U.S. subjects. The compartmental model is similar to that presented previously for 1 human subject (28) and to a model recently developed for rats (34). In all cases, several compartments were required to describe the complex processes of VA digestion, absorption, and initial hepatic processing. In the model developed to fit rat data (34), 2 extravascular compartments, one a faster turning-over pool and the other more slowly turning-over, were required to fit serum tracer data, whereas in the human subjects studied here, 1 extravascular compartment was adequate to fit the data (Fig. 2). We speculate that this difference may be the result of the timing of blood sampling and the larger VA pool in humans, which resulted in "lumping" of the more rapidly turning-over VA with the more slowly turning-over pool. It is likely that a 2nd, more rapidly turning-over compartment would be required to fit data from humans with low to marginal VA stores.
Our model predicted differences in whole-body VA kinetics between the Chinese and U.S. subjects. Specifically, the mean model-predicted VA disposal rate, total traced mass, and VA T(I,J) in the slow turning-over compartment (compartment 6, Fig. 2) were significantly greater in the U.S. subjects (Table 3). Previous studies have demonstrated that serum retinol is the main determinant of VA disposal rate in rats with low to moderate VA intake (16), whereas VA status affected disposal rate in rats with higher liver stores (15). Our results appear to support those observed in rats with high liver VA stores (15) by showing that the model-predicted VA disposal rate was strongly correlated to VA total traced mass in Chinese (Fig. 3A), U.S. (Fig. 3B), and all subjects (Fig. 4A). Moreover, when we compared VA disposal rate to serum retinol concentrations in all subjects, we observed that retinol concentrations were correlated with VA disposal rate (Fig. 4B,C), indicating that serum retinol also contributes to whole-body VA disposal as previously reported (16).
In this study, both the Chinese and U.S. subjects were VA adequate. However, serum retinol concentrations were significantly higher in the U.S. adults than in Chinese adults. Based on these results, we hypothesize that, as VA stores increase, there is a parallel increase in serum VA concentrations, which results in increased VA disposal rate as observed in rat models (15,16). In contrast, as VA stores decrease over time, such as during VA deficiency, there will be a decrease in serum retinol concentrations that will result in decreased VA disposal rate to conserve VA. This hypothesis is supported by the findings of Sauberlich et al. (17), who showed that both plasma retinol concentrations and disposal decreased over time during VA depletion. Thus, differences in VA nutriture will lead to changes in VA kinetics that will alter VA disposal rate to either conserve VA (VA deficiency) or prevent excessive accumulation of VA (VA sufficiency) even when VA levels are adequate.
With regard to VA stores, previous work has demonstrated that the liver is the primary storage site for VA in rats and humans when VA intake is normal (35–37). It was therefore of interest to compare our model-predicted VA total traced masses to liver VA levels measured by biopsy in an older study (27). To make this comparison, we assumed that the model-predicted total traced mass in compartment 6 was equivalent to liver VA; we calculated liver VA concentration by assuming that the liver comprises 2.4% of total body weight (27). Using these assumptions, VA nutriture for both Chinese and U.S. subjects was adequate (>0.07 µmol/g) (38) and compared favorably to hepatic VA concentrations that had been measured previously (27). Moreover, our model-predicted VA stores are similar to the values determined by isotope dilution (Fig. 5; 27,28). These results suggest that model-based compartmental analysis could be a useful tool to estimate whole-body VA stores in individuals. Advantages of this method are that, in addition to estimating whole-body VA mass as opposed to only hepatic levels, other useful information (such as estimates of VA intake, retinol recycling, T(I,J), utilization rate, and distribution) is obtained. Although the technique requires only a low dose of stable isotope-labeled retinol, studies need to be carried out for a long period of time (
50 d) and numerous blood samples are required.
When the DRD equation (27,28) was used here to estimate liver VA stores, data did not differ from 3 d and 24 d after dose administration (Fig. 5). Our results appear to support those in elderly Guatemalan men and women (30) by showing that liver VA stores can be estimated 3 d after tracer administration, thus increasing the efficacy of the DRD technique. Future studies should be conducted to validate and expand this finding so that a 3-d DRD equation can be developed to calculate an individual's VA stores.
In conclusion, a variety of techniques have been employed to attempt to determine the effect of dietary VA and VA status on the turnover and disposal of VA so that dietary requirements may be accurately estimated. Because the recommended daily allowances are set to meet the requirements for nearly all healthy individuals in a given age and gender group, this study was conducted to better understand VA kinetics in 2 groups of well-nourished individuals (Chinese vs. Americans). To our knowledge, this is the first study to use model-based compartmental analysis to examine whole-body VA kinetics for the purpose of determining the effect of VA stores on VA turnover and disposal rate in humans. The results of our work demonstrate that VA disposal rate is strongly associated with VA stores, suggesting that VA stores are a major determinant of VA disposal rate in well-nourished humans. Furthermore, we show that both model-based compartmental analysis and a modified DRD equation using 3-d data provide a good quantitative estimate of VA pool size in humans. Additional studies should be conducted to determine VA disposal in culturally diverse groups of humans across a range of VA nutriture and age.
| FOOTNOTES |
|---|
2 Author disclosures: C. J. Cifelli, J. B. Green, Z. Wang, S. Yin, R. M. Russell, G. Tang, and M. H. Green, no conflicts of interest. ![]()
7 Abbreviations used: DRD, deuterated retinol dilution; L(I,J), fractional transfer coefficient; M(I), mass in compartment I; RAc, retinyl acetate; RBP, retinol-binding protein; T(I,J), residence time; VA, vitamin A; WinSAAM, Windows version of the Simulation, Analysis and Modeling software. ![]()
Manuscript received 28 January 2008. Initial review completed 13 February 2008. Revision accepted 28 February 2008.
| LITERATURE CITED |
|---|
|
|
|---|
1. Goodman DS. Vitamin A and retinoids in health and disease. N Engl J Med. 1984;310:1023–31.[Medline]
2. Gudas LJ, Sporn MB, Roberts AB. Cellular biology and biochemistry of the retinoids. 2nd ed. New York: Raven Press; 1994.
3. West KP Jr. Extent of vitamin A deficiency among preschool children and women of reproductive age. J Nutr. 2002;132:S2857–66.
4. Food and Nutrition Board, The Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.
5. Semba RD, Bloem MW. The anemia of vitamin A deficiency: epidemiology and pathogenesis. Eur J Clin Nutr. 2002;56:271–81.[Medline]
6. Jang JT, Green JB, Beard JL, Green MH. Kinetic analysis shows that iron deficiency decreases liver vitamin A mobilization in rats. J Nutr. 2000;130:1291–6.
7. Kelley SK, Nilsson CB, Green MH, Green JB, Håkansson H. Use of model-based compartmental analysis to study effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A kinetics in rats. Toxicol Sci. 1998;44:1–13.
8. Kelley SK, Nilsson CB, Green MH, Green JB, Håkansson H. Mobilization of vitamin A stores in rats after administration of 2,3, 7,8-tetrachlorodibenzo-p-dioxin: a kinetic analysis. Toxicol Sci. 2000;55:478–84.
9. Hussey GD, Klein M. Measles-induced vitamin A deficiency. Ann N Y Acad Sci. 1992;669:188–94.[Medline]
10. Rosales FJ, Ross AC. Acute inflammation induces hyporetinemia and modifies the plasma and tissue response to vitamin A supplementation in marginally vitamin A-deficient rats. J Nutr. 1998;128:960–6.
11. Rosales FJ, Topping JD, Smith JE, Shankar AH, Ross AC. Relation of serum retinol to acute phase proteins and malarial morbidity in Papua New Guinea children. Am J Clin Nutr. 2000;71:1582–8.
12. Gieng SH, Raila J, Rosales FJ. Accumulation of retinol in the liver after prolonged hyporetinolemia in the vitamin A-sufficient rat. J Lipid Res. 2005;46:641–9.
13. Varma RN, Beaton GH. Quantitative aspects of the urinary and fecal excretion of radioactive metabolites of vitamin A in the rat. Can J Physiol Pharmacol. 1972;50:1026–37.[Medline]
14. Hicks VA, Gunning DB, Olson JA. Metabolism, plasma transport and biliary excretion of radioactive vitamin A and its metabolites as a function of liver reserves of vitamin A in the rat. J Nutr. 1984;114:1327–33.
15. Green MH, Green JB, Lewis KC. Variation in retinol utilization rate with vitamin A status in the rat. J Nutr. 1987;117:694–703.
16. Kelley SK, Green MH. Plasma retinol is a major determinant of vitamin A utilization in rats. J Nutr. 1998;128:1767–73.
17. Sauberlich HE, Hodges RE, Wallace DL, Kolder H, Canham JE, Hood J, Raica Jr N, Lowry LK. Vitamin A metabolism and requirements in the human studied with the use of labeled retinol. Vitam Horm. 1974;32:251–75.[Medline]
18. von Reinersdorff D, Bush E, Liberato DJ. Plasma kinetics of vitamin A in humans after a single oral dose of [8,9,19–13C]retinyl palmitate. J Lipid Res. 1996;37:1875–85.[Abstract]
19. von Reinersdorff D, Green MH, Green JB. Development of a compartmental model describing the dynamics of vitamin A metabolism in men. Adv Exp Med Biol. 1998;445:207–23.[Medline]
20. Green MH, Uhl L, Green JB. A multicompartmental model of vitamin A kinetics in rats with marginal liver vitamin A stores. J Lipid Res. 1985;26:806–18.[Abstract]
21. Wang Z, Yin S, Zhao X, Russell RM, Tang G. β-Carotene-vitamin A equivalence in Chinese adults assessed by an isotope dilution technique. Br J Nutr. 2004;91:121–31.[Medline]
22. Tang G, Qin J, Dolnikowski GG, Russell RM. Short-term (intestinal) and long-term (postintestinal) conversion of beta-carotene to retinol in adults as assessed by a stable-isotope reference method. Am J Clin Nutr. 2003;78:259–66.
23. Wang L. Plasma volume, cell volume, total blood volume and Fcells factor in the normal and splenectomized Sherman rat. Am J Physiol. 1959;196:188–92.[Medline]
24. Wastney ME, Patterson BH, Linares OA, Greif PC, Boston RC. Investigating biological systems using modeling. San Diego: Academic Press; 1999.
25. Green MH, Green JB. Experimental and kinetic methods for studying vitamin A dynamics in vivo. Methods Enzymol. 1990;190:304–17.[Medline]
26. Landaw EM, DiStefano JJ III. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol. 1984;246:R665–77.[Medline]
27. Furr HC, Amedee-Manesme O, Clifford AJ, Bergen HR III, Jones AD, Anderson DP, Olsen JA. Vitamin A concentrations in liver determined by isotope dilution assay with tetradeuterated vitamin A and by biopsy in generally healthy adult humans. Am J Clin Nutr. 1989;49:713–6.
28. Furr HC, Green MH, Haskell M, Mokhtar N, Nestel P, Newton S, Ribaya-Mercado JD, Tang G, Tanumihardjo S, Wasantwisut E. Stable isotope dilution techniques for assessing vitamin A status and bioefficacy of provitamin A carotenoids in humans. Public Health Nutr. 2005;8:596–607.[Medline]
29. Haskell MJ, Handelman GJ, Peerson JM, Jones AD, Rabbi MA, Awal MA, Wahed MA, Mahalanabis D, Brown KH. Assessment of vitamin A status by the deuterated-retinol-dilution technique and comparison with hepatic vitamin A concentration in Bangladeshi surgical patients. Am J Clin Nutr. 1997;66:67–74.
30. Ribaya-Mercado JD, Mazariegos M, Tang G, Romero-Abal ME, Mena I, Solomons NW, Russell RM. Assessment of total body stores of vitamin A in Guatemalan elderly by the deuterated-retinol-dilution method. Am J Clin Nutr. 1999;69:278–84.
31. Allen LE, Green MH, Green JB. Correspondence re: S.E. Dew et al., Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes (Cancer Res., 53: 2965–9, 1993). Cancer Res. 1994;54:3319–20.
32. Lewis KC, Green MH, Green JB, Zech LA. Retinol metabolism in rats with low vitamin A status: a compartmental model. J Lipid Res. 1990;31:1535–48.[Abstract]
33. Cifelli CJ, Green JB, Green MH. Dietary retinoic acid alters vitamin A kinetics in both the whole body and in specific organs of rats with low vitamin A status. J Nutr. 2005;135:746–52.
34. Gieng SH, Green MH, Green JB, Rosales FJ. Model-based compartmental analysis indicates a reduced mobilization of hepatic vitamin A during inflammation in rats. J Lipid Res. 2007;48:904–13.
35. Green MH, Green JB, Berg T, Norum KR, Blomhoff R. Changes in hepatic parenchymal and nonparenchymal cell vitamin A content during vitamin A depletion in the rat. J Nutr. 1988;118:1331–5.
36. Moriwaki H, Blaner WS, Piantedosi R, Goodman DS. Effects of dietary retinoid and triglyceride on the lipid composition of rat liver stellate cells and stellate cell lipid droplets. J Lipid Res. 1988;29:1523–34.[Abstract]
37. Blomhoff R, Green MH, Green JB, Berg T, Norum KR. Vitamin A metabolism: new perspectives on absorption, transport, and storage. Physiol Rev. 1991;71:951–90.
38. Olson JA. Recommended dietary intakes (RDI) of vitamin A in humans. Am J Clin Nutr. 1987;45:704–16.
This article has been cited by other articles:
![]() |
A. L. Escaron, M. H. Green, J. A. Howe, and S. A. Tanumihardjo Mathematical Modeling of Serum 13C-Retinol in Captive Rhesus Monkeys Provides New Insights on Hypervitaminosis A J. Nutr., October 1, 2009; 139(10): 2000 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Ho, F. F. de Moura, S.-H. Kim, B. J. Burri, and A. J. Clifford A Minute Dose of 14C-{beta}-Carotene Is Absorbed and Converted to Retinoids in Humans J. Nutr., August 1, 2009; 139(8): 1480 - 1486. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||